Russell Investments Group
RCEL icon

Russell Investments Group’s Avita Medical RCEL Stock Holding History

Russell Investments Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.3K Buy
18,471
+10,424
+130% +$43.8K ﹤0.01% 3207
2025
Q4 		$27.8K Buy
8,047
+4,425
+122% +$17.7K ﹤0.01% 3508
2025
Q3 		$18.5K Sell
3,622
-1,019
-22% -$5.32K ﹤0.01% 3607
2025
Q2 		$24.6K Sell
4,641
-1,756
-27% -$12.8K ﹤0.01% 3149
2025
Q1 		$52.1K Sell
6,397
-767
-11% -$7.17K ﹤0.01% 2902
2024
Q4 		$91.7K Buy
7,164
+2,324
+48% +$27.4K ﹤0.01% 2702
2024
Q3 		$51.9K Buy
4,840
+2,732
+130% +$25.7K ﹤0.01% 2784
2024
Q2 		$16.7K Buy
2,108
+1,602
+317% +$15.2K ﹤0.01% 2971
2024
Q1 		$8.11K Buy
506
+286
+130% +$4.63K ﹤0.01% 2874
2023
Q4 		$3.02K Sell
220
-368,245
-100% -$4.22M ﹤0.01% 2958
2023
Q3 		$5.38M Buy
368,465
+152,947
+71% +$2.59M 0.01% 1044
2023
Q2 		$3.67M Buy
+215,518
New +$3.16M 0.01% 1226
2022
Q3 		– Sell
-2,002
Closed -$9K – 2960
2022
Q2 		$9K Sell
2,002
-1,601
-44% -$9.89K ﹤0.01% 2847
2022
Q1 		$30K Buy
+3,603
New +$33.2K ﹤0.01% 2660

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Russell Investments Group's RCEL Position: Q1 2026 in Review

Russell Investments Group increased its Avita Medical (RCEL) stake by 130% in Q1 2026, buying an estimated $43.8K and bringing the position to 18,471 shares worth $68.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Russell Investments Group first reported a position in RCEL in Q1 2022 and has held it in 14 quarters since. The position peaked at $5.38M in Q3 2023. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Russell Investments Group held 18,471 shares of Avita Medical worth $68.3K as of Q1 2026.
  • Russell Investments Group bought 10,424 Avita Medical shares in Q1 2026, an estimated $43.8K.
  • Avita Medical made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3207 holding.
  • Russell Investments Group first reported a position in Avita Medical in Q1 2022 and has held it in 14 quarters since.
  • Russell Investments Group's Avita Medical position peaked at $5.38M in Q3 2023.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.